{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:47:01Z","timestamp":1787579221382,"version":"build-2736575974"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10529-021-03211-0","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T08:02:45Z","timestamp":1638000165000},"page":"45-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9991-4931","authenticated-orcid":false,"given":"Farshad","family":"Hemmati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Hemmati-Dinarvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziye","family":"Karimzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayyad","family":"Khanizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Afsharifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"issue":"2","key":"3211_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2567.2007.02753.x","volume":"124","author":"E Acosta-Ram\u00edrez","year":"2008","unstructured":"Acosta-Ram\u00edrez E, P\u00e9rez-Flores R, Majeau N et al (2008) Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus. Immunology 124(2):186\u2013197","journal-title":"Immunology"},{"issue":"4","key":"3211_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/vaccines7040132","volume":"7","author":"N Armbruster","year":"2019","unstructured":"Armbruster N, Jasny E, Petsch B (2019) Advances in RNA vaccines for preventive indications: a case study of a vaccine against rabies. Vaccines 7(4):132","journal-title":"Vaccines"},{"issue":"1","key":"3211_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3155-11-10","volume":"11","author":"C Babin","year":"2013","unstructured":"Babin C, Majeau N, Leclerc D (2013) Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP. J Nanobiotechnol 11(1):1\u20138","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"3211_CR4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10(11):787\u2013796","journal-title":"Nat Rev Immunol"},{"issue":"5138","key":"3211_CR5","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","volume":"262","author":"MF Bachmann","year":"1993","unstructured":"Bachmann MF, Rohrer UH, Kundig TM et al (1993) The influence of antigen organization on B cell responsiveness. Science 262(5138):1448\u20131451","journal-title":"Science"},{"issue":"1","key":"3211_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jmbi.1999.2860","volume":"290","author":"M Bendahmane","year":"1999","unstructured":"Bendahmane M, Koo M, Karrer E et al (1999) Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions. J Mol Biol 290(1):9\u201320","journal-title":"J Mol Biol"},{"issue":"17","key":"3211_CR7","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1128\/JVI.77.17.9211-9220.2003","volume":"77","author":"S Biemelt","year":"2003","unstructured":"Biemelt S, Sonnewald U, Galmbacher P et al (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol 77(17):9211\u20139220","journal-title":"J Virol"},{"issue":"15\u201316","key":"3211_CR8","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0264-410X(98)00485-X","volume":"17","author":"F Brennan","year":"1999","unstructured":"Brennan F, Jones T, Longstaff M et al (1999) Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 17(15\u201316):1846\u20131857","journal-title":"Vaccine"},{"issue":"11","key":"3211_CR9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1586\/erv.11.135","volume":"10","author":"L Buonaguro","year":"2011","unstructured":"Buonaguro L, Tagliamonte M, Tornesello ML et al (2011) Developments in virus-like particle-based vaccines for infectious diseases and cancer. Expert Rev Vaccines 10(11):1569\u20131583","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"3211_CR10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/vaccines7030072","volume":"7","author":"G Cabral-Miranda","year":"2019","unstructured":"Cabral-Miranda G, Lim SM, Mohsen MO et al (2019) Zika virus-derived E-DIII protein displayed on immunologically optimized VLPs induces neutralizing antibodies without causing enhancement of dengue virus infection. Vaccines 7(3):72","journal-title":"Vaccines"},{"issue":"7","key":"3211_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.tplants.2020.04.009","volume":"25","author":"T Capell","year":"2020","unstructured":"Capell T, Twyman RM, Armario-Najera V et al (2020) Potential applications of plant biotechnology against SARS-CoV-2. Trends Plant Sci 25(7):635\u2013643","journal-title":"Trends Plant Sci"},{"issue":"51","key":"3211_CR12","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1016\/j.vaccine.2015.10.123","volume":"33","author":"D Carignan","year":"2015","unstructured":"Carignan D, Th\u00e9rien A, Rioux G et al (2015) Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine. Vaccine 33(51):7245\u20137253","journal-title":"Vaccine"},{"issue":"1","key":"3211_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1104\/pp.108.117572","volume":"147","author":"A Castilho","year":"2008","unstructured":"Castilho A, Pabst M, Leonard R et al (2008) Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol 147(1):331\u2013339","journal-title":"Plant Physiol"},{"issue":"21","key":"3211_CR14","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1074\/jbc.M109.088401","volume":"285","author":"A Castilho","year":"2010","unstructured":"Castilho A, Strasser R, Stadlmann J et al (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285(21):15923\u201315930","journal-title":"J Biol Chem"},{"issue":"6","key":"3211_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/glycob\/cwr009","volume":"21","author":"A Castilho","year":"2011","unstructured":"Castilho A, Gattinger P, Grass J et al (2011) N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 21(6):813\u2013823","journal-title":"Glycobiology"},{"key":"3211_CR16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fpls.2019.00779","volume":"10","author":"A Chabeda","year":"2019","unstructured":"Chabeda A, van Zyl AR, Rybicki EP et al (2019) Substitution of human papillomavirus type 16 L2 neutralizing epitopes into L1 surface loops: the effect on virus-like particle assembly and immunogenicity. Front Plant Sci 10:779","journal-title":"Front Plant Sci"},{"issue":"3","key":"3211_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","volume":"6","author":"B Chackerian","year":"2007","unstructured":"Chackerian B (2007) Virus-like particles: flexible platforms for vaccine development. Expert Rev Vaccines 6(3):381\u2013390","journal-title":"Expert Rev Vaccines"},{"issue":"37\u201339","key":"3211_CR18","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1016\/j.vaccine.2006.05.059","volume":"24","author":"B Chackerian","year":"2006","unstructured":"Chackerian B, Rangel M, Hunter Z et al (2006) Virus and virus-like particle-based immunogens for Alzheimer\u2019s disease induce antibody responses against amyloid-\u03b2 without concomitant T cell responses. Vaccine 24(37\u201339):6321\u20136331","journal-title":"Vaccine"},{"issue":"4","key":"3211_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.13031\/2013.26854","volume":"1","author":"Q Chen","year":"2008","unstructured":"Chen Q (2008) Expression and purification of pharmaceutical proteins in plants. Biol Eng Trans 1(4):291\u2013321","journal-title":"Biol Eng Trans"},{"issue":"1","key":"3211_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12250-016-3726-4","volume":"31","author":"Y Chen","year":"2016","unstructured":"Chen Y, Guo D (2016) Molecular mechanisms of coronavirus RNA capping and methylation. Virol Sin 31(1):3\u201311","journal-title":"Virol Sin"},{"issue":"1","key":"3211_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.22218","volume":"9","author":"Q Chen","year":"2013","unstructured":"Chen Q, Lai H (2013) Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother 9(1):26\u201349","journal-title":"Hum Vaccin Immunother"},{"issue":"48","key":"3211_CR22","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.3748\/wjg.v12.i48.7774","volume":"12","author":"JY Chen","year":"2006","unstructured":"Chen JY, Li F (2006) Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier. World J Gastroenterol 12(48):7774","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3211_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4161\/hv.7.3.14262","volume":"7","author":"Q Chen","year":"2011","unstructured":"Chen Q, He J, Phoolcharoen W, Mason HS (2011) Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum Vaccin 7(3):331\u2013338","journal-title":"Hum Vaccin"},{"issue":"39","key":"3211_CR24","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1016\/j.vaccine.2018.08.033","volume":"36","author":"JA Chichester","year":"2018","unstructured":"Chichester JA, Green BJ, Jones RM et al (2018) Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: a phase 1 dose-escalation study in healthy adults. Vaccine 36(39):5865\u20135871","journal-title":"Vaccine"},{"key":"3211_CR25","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2020.06.024","volume":"156","author":"YH Chung","year":"2020","unstructured":"Chung YH, Cai H, Steinmetz NF (2020) Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Adv Drug Deliv Rev 156:214\u2013235","journal-title":"Adv Drug Deliv Rev"},{"issue":"6146","key":"3211_CR26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","volume":"330","author":"B Clarke","year":"1987","unstructured":"Clarke B, Newton S, Carroll A et al (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330(6146):381\u2013384","journal-title":"Nature"},{"issue":"12","key":"3211_CR27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/nbt1260","volume":"24","author":"KM Cox","year":"2006","unstructured":"Cox KM, Sterling JD, Regan JT et al (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24(12):1591\u20131597","journal-title":"Nat Biotechnol"},{"issue":"9","key":"3211_CR28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1467-7652.2008.00384.x","volume":"6","author":"MA D\u2019Aoust","year":"2008","unstructured":"D\u2019Aoust MA, Lavoie PO, Couture MMJ et al (2008) Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J 6(9):930\u2013940","journal-title":"Plant Biotechnol J"},{"issue":"8","key":"3211_CR29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1467-7652.2010.00550.x","volume":"8","author":"HM Davies","year":"2010","unstructured":"Davies HM (2010) Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8(8):845\u2013861","journal-title":"Plant Biotechnol J"},{"issue":"1","key":"3211_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-6-1","volume":"6","author":"GP De la Rosa","year":"2009","unstructured":"De la Rosa GP, Monroy-Garc\u00eda A, de Lourdes M-G et al (2009) An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virol J 6(1):1\u201311","journal-title":"Virol J"},{"issue":"3","key":"3211_CR31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biotechadv.2009.01.008","volume":"27","author":"AL Demain","year":"2009","unstructured":"Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27(3):297\u2013306","journal-title":"Biotechnol Adv"},{"issue":"1","key":"3211_CR32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2007.01.011","volume":"363","author":"J Denis","year":"2007","unstructured":"Denis J, Majeau N, Acosta-Ramirez E et al (2007) Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology 363(1):59\u201368","journal-title":"Virology"},{"issue":"1","key":"3211_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vaccine.2018.11.021","volume":"37","author":"AG Diamos","year":"2019","unstructured":"Diamos AG, Larios D, Brown L et al (2019) Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen. Vaccine 37(1):137\u2013144","journal-title":"Vaccine"},{"issue":"18","key":"3211_CR34","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.vaccine.2020.02.089","volume":"38","author":"AG Diamos","year":"2020","unstructured":"Diamos AG, Pardhe MD, Sun H et al (2020) Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity. Vaccine 38(18):3455\u20133463","journal-title":"Vaccine"},{"issue":"20","key":"3211_CR35","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","volume":"348","author":"C Drosten","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W et al (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348(20):1967\u20131976","journal-title":"N Engl J Med"},{"issue":"3","key":"3211_CR36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y et al (2009) The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nat Rev Microbiol 7(3):226\u2013236","journal-title":"Nat Rev Microbiol"},{"issue":"5815","key":"3211_CR37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/291503a0","volume":"291","author":"JC Edman","year":"1981","unstructured":"Edman JC, Hallewell RA, Valenzuela P et al (1981) Synthesis of hepatitis B surface and core antigens in E. coli. Nature 291(5815):503\u2013506","journal-title":"Nature"},{"issue":"11","key":"3211_CR38","first-page":"588","volume":"3","author":"A El Attar","year":"2004","unstructured":"El Attar A, Shamloul A, Shalaby A et al (2004) Expression of chimeric HCV peptide in transgenic tobacco plants infected with recombinant alfalfa mosaic virus for development of a plant-derived vaccine against HCV. Afr J Biotech 3(11):588\u2013594","journal-title":"Afr J Biotech"},{"key":"3211_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-7652.2010.00521.x","author":"L Faye","year":"2010","unstructured":"Faye L, Gomord V (2010) Success stories in molecular farming\u2013a brief overview. Plant Biotechnol J. https:\/\/doi.org\/10.1111\/j.1467-7652.2010.00521.x","journal-title":"Plant Biotechnol J"},{"key":"3211_CR40","first-page":"1","volume-title":"Coronaviruses: an overview of their replication and pathogenesis Coronaviruses","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis Coronaviruses. Springer, New York, pp 1\u201323"},{"issue":"16","key":"3211_CR41","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","volume":"95","author":"T Fehr","year":"1998","unstructured":"Fehr T, Skrastina D, Pumpens P, Zinkernagel RM (1998) T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci 95(16):9477\u20139481","journal-title":"Proc Natl Acad Sci"},{"issue":"10249","key":"3211_CR42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti PM, Ewer KJ, Aley PK et al (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. The Lancet 396(10249):467\u2013478","journal-title":"The Lancet"},{"issue":"7","key":"3211_CR43","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1073\/pnas.87.7.2545","volume":"87","author":"MJ Francis","year":"1990","unstructured":"Francis MJ, Hastings GZ, Brown AL et al (1990) Immunological properties of hepatitis B core antigen fusion proteins. Proc Natl Acad Sci 87(7):2545\u20132549","journal-title":"Proc Natl Acad Sci"},{"key":"3211_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","volume":"39","author":"J Fuenmayor","year":"2017","unstructured":"Fuenmayor J, G\u00f2dia F, Cervera L (2017) Production of virus-like particles for vaccines. New Biotechnol 39:174\u2013180","journal-title":"New Biotechnol"},{"issue":"3","key":"3211_CR45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/v13030418","volume":"13","author":"CD Funk","year":"2021","unstructured":"Funk CD, Laferri\u00e8re C, Ardakani A (2021) Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond: an early 2021 perspective. Viruses 13(3):418","journal-title":"Viruses"},{"issue":"7477","key":"3211_CR46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"XY Ge","year":"2013","unstructured":"Ge XY, Li JL, Yang XL et al (2013) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 503(7477):535\u2013538","journal-title":"Nature"},{"key":"3211_CR47","first-page":"e52459","volume":"97","author":"E Gecchele","year":"2015","unstructured":"Gecchele E, Merlin M, Brozzetti A et al (2015) A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems. J vis Exp 97:e52459","journal-title":"J vis Exp"},{"issue":"5","key":"3211_CR48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0958-1669(00)00244-5","volume":"12","author":"G Giddings","year":"2001","unstructured":"Giddings G (2001) Transgenic plants as protein factories. Curr Opin Biotechnol 12(5):450\u2013454","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"3211_CR49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-7652.2009.00497.x","volume":"8","author":"V Gomord","year":"2010","unstructured":"Gomord V, Fitchette AC, Menu-Bouaouiche L et al (2010) Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 8(5):564\u2013587","journal-title":"Plant Biotechnol J"},{"issue":"2","key":"3211_CR50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/v12020135","volume":"12","author":"LE Gralinski","year":"2020","unstructured":"Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12(2):135","journal-title":"Viruses"},{"issue":"49","key":"3211_CR51","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1016\/j.vaccine.2007.09.061","volume":"25","author":"R Greco","year":"2007","unstructured":"Greco R, Michel M, Guetard D et al (2007) Production of recombinant HIV-1\/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine 25(49):8228\u20138240","journal-title":"Vaccine"},{"issue":"1","key":"3211_CR52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","volume":"40","author":"EV Grgacic","year":"2006","unstructured":"Grgacic EV, Anderson DA (2006) Virus-like particles: passport to immune recognition. Methods 40(1):60\u201365","journal-title":"Methods"},{"issue":"4","key":"3211_CR53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jinf.2020.02.010","volume":"80","author":"Q Han","year":"2020","unstructured":"Han Q, Lin Q, Jin S, You L (2020) Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect 80(4):373\u2013377","journal-title":"J Infect"},{"issue":"2","key":"3211_CR54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/vim.2005.18.327","volume":"18","author":"Y He","year":"2005","unstructured":"He Y, Jiang S (2005) Vaccine design for severe acute respiratory syndrome coronavirus. Viral Immunol 18(2):327\u2013332","journal-title":"Viral Immunol"},{"key":"3211_CR55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-15-2651-0_11","volume-title":"The middle east respiratory syndrome coronavirus (mers-cov) animal-origin viral zoonoses","author":"MG Hemida","year":"2020","unstructured":"Hemida MG (2020) The middle east respiratory syndrome coronavirus (mers-cov) animal-origin viral zoonoses. Springer, Singapore, pp 241\u2013254"},{"key":"3211_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.04.022","author":"F Hemmati","year":"2020","unstructured":"Hemmati F, Saedi S, Hemmati-Dinarvand M et al (2020) Mysterious virus: a review on behavior and treatment approaches of the novel coronavirus, 2019-nCoV. Arch Med Res. https:\/\/doi.org\/10.1016\/j.arcmed.2020.04.022","journal-title":"Arch Med Res"},{"issue":"3","key":"3211_CR57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1467-7652.2004.00068.x","volume":"2","author":"Z Huang","year":"2004","unstructured":"Huang Z, Mason HS (2004) Conformational analysis of hepatitis B surface antigen fusions in an agrobacterium-mediated transient expression system. Plant Biotechnol J 2(3):241\u2013249","journal-title":"Plant Biotechnol J"},{"issue":"14","key":"3211_CR58","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","volume":"24","author":"Z Huang","year":"2006","unstructured":"Huang Z, Santi L, LePore K et al (2006) Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24(14):2506\u20132513","journal-title":"Vaccine"},{"issue":"4","key":"3211_CR59","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","volume":"103","author":"Z Huang","year":"2009","unstructured":"Huang Z, Chen Q, Hjelm B et al (2009) A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng 103(4):706\u2013714","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"3211_CR60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2005.09.060","volume":"24","author":"L Jiang","year":"2006","unstructured":"Jiang L, Li Q, Li M et al (2006) A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco. Vaccine 24(2):109\u2013115","journal-title":"Vaccine"},{"issue":"20","key":"3211_CR61","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","volume":"348","author":"TG Ksiazek","year":"2003","unstructured":"Ksiazek TG, Erdman D, Goldsmith CS et al (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348(20):1953\u20131966","journal-title":"N Engl J Med"},{"issue":"1","key":"3211_CR62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","volume":"31","author":"N Kushnir","year":"2012","unstructured":"Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31(1):58\u201383","journal-title":"Vaccine"},{"issue":"2","key":"3211_CR63","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/JVI.01811-07","volume":"82","author":"P Lacasse","year":"2008","unstructured":"Lacasse P, Denis J, Lapointe R et al (2008) Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation. J Virol 82(2):785\u2013794","journal-title":"J Virol"},{"issue":"2","key":"3211_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/vaccines7020049","volume":"7","author":"M\u00c8 Lalibert\u00e9-Gagn\u00e9","year":"2019","unstructured":"Lalibert\u00e9-Gagn\u00e9 M\u00c8, Bolduc M, Th\u00e9rien A et al (2019) Increased immunogenicity of full-length protein antigens through sortase-mediated coupling on the PapMV vaccine platform. Vaccines 7(2):49","journal-title":"Vaccines"},{"issue":"4\u20136","key":"3211_CR65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000067912","volume":"45","author":"F Lechner","year":"2002","unstructured":"Lechner F, Jegerlehner A, Tissot AC et al (2002) Virus-like particles as a modular system for novel vaccines. Intervirology 45(4\u20136):212\u2013217","journal-title":"Intervirology"},{"issue":"1","key":"3211_CR66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2672.2011.05176.x","volume":"112","author":"KW Lee","year":"2012","unstructured":"Lee KW, Tey BT, Ho KL, Tan WS (2012) Delivery of chimeric hepatitis B core particles into liver cells. J Appl Microbiol 112(1):119\u2013131","journal-title":"J Appl Microbiol"},{"key":"3211_CR67","volume-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","author":"G Li","year":"2020","unstructured":"Li G, De Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Publishing Group, Berlin"},{"issue":"4","key":"3211_CR68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y et al (2020) Coronavirus infections and immune responses. J Med Virol 92(4):424\u2013432","journal-title":"J Med Virol"},{"issue":"2","key":"3211_CR69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcp.21423","volume":"216","author":"C Lico","year":"2008","unstructured":"Lico C, Chen Q, Santi L (2008) Viral vectors for production of recombinant proteins in plants. J Cell Physiol 216(2):366\u2013377","journal-title":"J Cell Physiol"},{"issue":"15","key":"3211_CR70","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.vaccine.2004.11.006","volume":"23","author":"L Liu","year":"2005","unstructured":"Liu L, Ca\u00f1izares MC, Monger W et al (2005) Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants. Vaccine 23(15):1788\u20131792","journal-title":"Vaccine"},{"key":"3211_CR71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coviro.2017.07.019","volume":"26","author":"HS Loh","year":"2017","unstructured":"Loh HS, Green BJ, Yusibov V (2017) Using transgenic plants and modified plant viruses for the development of treatments for human diseases. Curr Opin Virol 26:81\u201389","journal-title":"Curr Opin Virol"},{"issue":"3","key":"3211_CR72","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/hv.18757","volume":"8","author":"C L\u00f3pez-Mac\u00edas","year":"2012","unstructured":"L\u00f3pez-Mac\u00edas C (2012) Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic. Hum Vaccines Immunother 8(3):411\u2013414","journal-title":"Hum Vaccines Immunother"},{"issue":"10","key":"3211_CR73","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrg1177","volume":"4","author":"JK Ma","year":"2003","unstructured":"Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4(10):794\u2013805","journal-title":"Nat Rev Genet"},{"issue":"7","key":"3211_CR74","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.embor.7400470","volume":"6","author":"JKC Ma","year":"2005","unstructured":"Ma JKC, Barros E, Bock R et al (2005) Molecular farming for new drugs and vaccines: current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 6(7):593\u2013599","journal-title":"EMBO Rep"},{"issue":"1","key":"3211_CR75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/vaccines9010015","volume":"9","author":"N Mahmood","year":"2021","unstructured":"Mahmood N, Nasir SB, Hefferon K (2021) Plant-based drugs and vaccines for COVID-19. Vaccines 9(1):15","journal-title":"Vaccines"},{"issue":"1","key":"3211_CR76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00365548.2011.608711","volume":"44","author":"IR Malik","year":"2012","unstructured":"Malik IR, Chen A, Brass A et al (2012) A bi-functional hepatitis B virus core antigen (HBcAg) chimera activates HBcAg-specific T cells and preS1-specific antibodies. Scand J Infect Dis 44(1):55\u201359","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"3211_CR77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/01652176.2020.1727993","volume":"40","author":"YS Malik","year":"2020","unstructured":"Malik YS, Sircar S, Bhat S et al (2020) Emerging novel coronavirus (2019-nCoV)\u2014current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q 40(1):68\u201376","journal-title":"Vet Q"},{"issue":"10","key":"3211_CR78","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1371\/journal.ppat.0030142","volume":"3","author":"DJ Manayani","year":"2007","unstructured":"Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Yeager M (2007) A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 3(10):e142","journal-title":"PLoS Pathog"},{"key":"3211_CR79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.copbio.2015.12.007","volume":"37","author":"J Marsian","year":"2016","unstructured":"Marsian J, Lomonossoff GP (2016) Molecular pharming\u2014VLPs made in plants. Curr Opin Biotechnol 37:201\u2013206","journal-title":"Curr Opin Biotechnol"},{"issue":"24","key":"3211_CR80","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1073\/pnas.89.24.11745","volume":"89","author":"HS Mason","year":"1992","unstructured":"Mason HS, Lam D, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci 89(24):11745\u201311749","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"3211_CR81","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.93.11.5335","volume":"93","author":"HS Mason","year":"1996","unstructured":"Mason HS, Ball JM, Shi JJ et al (1996) Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci 93(11):5335\u20135340","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3211_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-11-106","volume":"11","author":"S Mati\u0107","year":"2011","unstructured":"Mati\u0107 S, Rinaldi R, Masenga V, Noris E (2011) Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol 11(1):1\u201312","journal-title":"BMC Biotechnol"},{"issue":"4","key":"3211_CR83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1467-7652.2011.00671.x","volume":"10","author":"S Mati\u0107","year":"2012","unstructured":"Mati\u0107 S, Masenga V, Poli A et al (2012) Comparative analysis of recombinant human papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods. Plant Biotechnol J 10(4):410\u2013421","journal-title":"Plant Biotechnol J"},{"issue":"7","key":"3211_CR84","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","volume":"35","author":"P Maurer","year":"2005","unstructured":"Maurer P, Jennings GT, Willers J et al (2005) A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity. Eur J Immunol 35(7):2031\u20132040","journal-title":"Eur J Immunol"},{"key":"3211_CR85","first-page":"500","volume":"24","author":"W McAleer","year":"1992","unstructured":"McAleer W, Buynak E, Maigetter R et al (1992) Human hepatitis B vaccine from recombinant yeast. 1984. Biotechnology (reading, Mass) 24:500\u2013502","journal-title":"Biotechnology (reading, Mass)"},{"issue":"1","key":"3211_CR86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.7.1.33","volume":"7","author":"AA McCormick","year":"2008","unstructured":"McCormick AA, Palmer KE (2008) Genetically engineered tobacco mosaic virus as nanoparticle vaccines. Expert Rev Vaccines 7(1):33\u201341","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"3211_CR87","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(95)00229-T","volume":"14","author":"L McLain","year":"1996","unstructured":"McLain L, Durrani Z, Wisniewski LA et al (1996) Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 14(8):799\u2013810","journal-title":"Vaccine"},{"issue":"1","key":"3211_CR88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2005.06.020","volume":"131","author":"I Mechtcheriakova","year":"2006","unstructured":"Mechtcheriakova I, Eldarov M, Nicholson L et al (2006) The use of viral vectors to produce hepatitis B virus core particles in plants. J Virol Methods 131(1):10\u201315","journal-title":"J Virol Methods"},{"issue":"1","key":"3211_CR89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6750-8-53","volume":"8","author":"A Meyers","year":"2008","unstructured":"Meyers A, Chakauya E, Shephard E et al (2008) Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol 8(1):53","journal-title":"BMC Biotechnol"},{"issue":"11","key":"3211_CR90","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apm.13074","volume":"128","author":"S Mohammadzadeh","year":"2020","unstructured":"Mohammadzadeh S, Roohvand F, Ehsani P et al (2020) Canola oilseed-and Escherichia coli-derived hepatitis C virus (HCV) core proteins adjuvanted with oil bodies, induced robust Th1-oriented immune responses in immunized mice. APMIS 128(11):593\u2013602","journal-title":"APMIS"},{"issue":"7830","key":"3211_CR91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","volume":"586","author":"MJ Mulligan","year":"2020","unstructured":"Mulligan MJ, Lyke KE, Kitchin N et al (2020) Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586(7830):589\u2013593","journal-title":"Nature"},{"issue":"1","key":"3211_CR92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pep.2008.01.011","volume":"59","author":"A Natilla","year":"2008","unstructured":"Natilla A, Nemchinov LG (2008) Improvement of PVX\/CMV CP expression tool for display of short foreign antigens. Protein Expr Purif 59(1):117\u2013121","journal-title":"Protein Expr Purif"},{"key":"3211_CR93","unstructured":"Palca J (2020) Tobacco plants contribute key ingredient for COVID-19 Vaccine. https:\/\/www.npr.org\/sections\/health-shots\/2020\/10\/15\/923210562\/tobacco-plants. Accessed 22 Dec 2020"},{"issue":"1\u20132","key":"3211_CR94","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vetimm.2007.08.010","volume":"121","author":"L Pan","year":"2008","unstructured":"Pan L, Zhang Y, Wang Y et al (2008) Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1\u20132A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs. Vet Immunol Immunopathol 121(1\u20132):83\u201390","journal-title":"Vet Immunol Immunopathol"},{"key":"3211_CR95","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fpls.2019.00455","volume":"10","author":"EL Pang","year":"2019","unstructured":"Pang EL, Peyret H, Ramirez A et al (2019) Epitope presentation of dengue viral envelope glycoprotein domain III on hepatitis B core protein virus-like particles produced in Nicotiana benthamiana. Front Plant Sci 10:455","journal-title":"Front Plant Sci"},{"issue":"1\u20132","key":"3211_CR96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11103-013-0036-1","volume":"83","author":"H Peyret","year":"2013","unstructured":"Peyret H, Lomonossoff GP (2013) The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants. Plant Mol Biol 83(1\u20132):51\u201358","journal-title":"Plant Mol Biol"},{"issue":"1","key":"3211_CR97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13007-019-0494-9","volume":"15","author":"H Peyret","year":"2019","unstructured":"Peyret H, Brown JK, Lomonossoff GP (2019) Improving plant transient expression through the rational design of synthetic 5\u2032 and 3\u2032 untranslated regions. Plant Methods 15(1):108","journal-title":"Plant Methods"},{"key":"3211_CR98","unstructured":"Phillip M (2020) https:\/\/www.pmi.com\/media-center\/news\/pmi-announces. Accessed 25 Oct 2020"},{"key":"3211_CR99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","volume":"168","author":"S Pillet","year":"2016","unstructured":"Pillet S, Aubin \u00c9, Tr\u00e9panier S et al (2016) A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Clin Immunol 168:72\u201387","journal-title":"Clin Immunol"},{"issue":"6","key":"3211_CR100","doi-asserted-by":"crossref","first-page":"e0216533","DOI":"10.1371\/journal.pone.0216533","volume":"14","author":"S Pillet","year":"2019","unstructured":"Pillet S, Couillard J, Tr\u00e9panier S et al (2019) Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate\u2014two randomized phase II clinical trials in 18 to 49 and\u2265 50 years old adults. PLoS ONE 14(6):e0216533","journal-title":"PLoS ONE"},{"issue":"2","key":"3211_CR101","first-page":"174","volume":"3","author":"EM Plummer","year":"2011","unstructured":"Plummer EM, Manchester M (2011) Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip Rev 3(2):174\u2013196","journal-title":"Wiley Interdiscip Rev"},{"issue":"4","key":"3211_CR102","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/pbi.13501","volume":"19","author":"D Ponndorf","year":"2021","unstructured":"Ponndorf D, Meshcheriakova Y, Thuenemann EC et al (2021) Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice. Plant Biotechnol J 19(4):745\u2013756","journal-title":"Plant Biotechnol J"},{"issue":"37","key":"3211_CR103","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1016\/j.vaccine.2013.06.039","volume":"31","author":"C Pulcini","year":"2013","unstructured":"Pulcini C, Massin S, Launay O, Verger P (2013) Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. Vaccine 31(37):3943\u20133949","journal-title":"Vaccine"},{"issue":"1","key":"3211_CR104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1134\/S000629791201004X","volume":"77","author":"N Ravin","year":"2012","unstructured":"Ravin N, Kotlyarov RY, Mardanova E et al (2012) Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein. Biochem Mosc 77(1):33\u201340","journal-title":"Biochem Mosc"},{"issue":"10","key":"3211_CR105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Roldao","year":"2010","unstructured":"Roldao A, Mellado MCM, Castilho LR et al (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9(10):1149\u20131176","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"3211_CR106","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/erv.12.150","volume":"12","author":"K Roose","year":"2013","unstructured":"Roose K, Baets SD, Schepens B, Saelens X (2013) Hepatitis B core\u2013based virus\u2013like particles to present heterologous epitopes. Expert Rev Vaccines 12(2):183\u2013198","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"3211_CR107","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/14712598.2020.1752177","volume":"20","author":"S Rosales-Mendoza","year":"2020","unstructured":"Rosales-Mendoza S (2020) Will plant-made biopharmaceuticals play a role in the fight against COVID-19? Expert Opin Biol Ther 20(6):545\u2013548","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"3211_CR108","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1104\/pp.108.126284","volume":"148","author":"F Sainsbury","year":"2008","unstructured":"Sainsbury F, Lomonossoff GP (2008) Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol 148(3):1212\u20131218","journal-title":"Plant Physiol"},{"issue":"3","key":"3211_CR109","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11103-014-0279-5","volume":"87","author":"JA Salazar-Gonz\u00e1lez","year":"2015","unstructured":"Salazar-Gonz\u00e1lez JA, Ba\u00f1uelos-Hern\u00e1ndez B, Rosales-Mendoza S (2015) Current status of viral expression systems in plants and perspectives for oral vaccines development. Plant Mol Biol 87(3):203\u2013217","journal-title":"Plant Mol Biol"},{"issue":"1","key":"3211_CR110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/vim.2006.19.42","volume":"19","author":"S Salda\u00f1a","year":"2006","unstructured":"Salda\u00f1a S, Guadarrama FE, Flores TDJO et al (2006) Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunol 19(1):42\u201353","journal-title":"Viral Immunol"},{"issue":"1","key":"3211_CR111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymeth.2006.05.020","volume":"40","author":"L Santi","year":"2006","unstructured":"Santi L, Huang Z, Mason H (2006) Virus-like particles production in green plants. Methods 40(1):66\u201376","journal-title":"Methods"},{"issue":"15","key":"3211_CR112","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.vaccine.2008.01.053","volume":"26","author":"L Santi","year":"2008","unstructured":"Santi L, Batchelor L, Huang Z et al (2008) An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 26(15):1846\u20131854","journal-title":"Vaccine"},{"issue":"15","key":"3211_CR113","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2004.11.014","volume":"23","author":"MJD Santos","year":"2005","unstructured":"Santos MJD, Carrillo C, Ardila F et al (2005) Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 23(15):1838\u20131843","journal-title":"Vaccine"},{"issue":"5","key":"3211_CR114","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1467-7652.2007.00273.x","volume":"5","author":"M Sch\u00e4hs","year":"2007","unstructured":"Sch\u00e4hs M, Strasser R, Stadlmann J et al (2007) Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 5(5):657\u2013663","journal-title":"Plant Biotechnol J"},{"issue":"19","key":"3211_CR115","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1128\/JVI.01088-09","volume":"83","author":"C Schellenbacher","year":"2009","unstructured":"Schellenbacher C, Roden R, Kirnbauer R (2009) Chimeric L1\u2013L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. J Virol 83(19):10085\u201310095","journal-title":"J Virol"},{"issue":"5","key":"3211_CR116","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00425-009-0898-2","volume":"229","author":"N Scotti","year":"2009","unstructured":"Scotti N, Alagna F, Ferraiolo E et al (2009) High-level expression of the HIV-1 Pr55 gag polyprotein in transgenic tobacco chloroplasts. Planta 229(5):1109\u20131122","journal-title":"Planta"},{"issue":"11","key":"3211_CR117","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1099\/0022-1317-82-11-2799","volume":"82","author":"K Slupetzky","year":"2001","unstructured":"Slupetzky K, Shafti-Keramat S, Lenz P et al (2001) Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops. J Gen Virol 82(11):2799\u20132804","journal-title":"J Gen Virol"},{"issue":"1","key":"3211_CR118","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/v11010059","volume":"11","author":"Z Song","year":"2019","unstructured":"Song Z, Xu Y, Bao L et al (2019) From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 11(1):59","journal-title":"Viruses"},{"issue":"16","key":"3211_CR119","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1073\/pnas.86.16.6283","volume":"86","author":"SJ Stahl","year":"1989","unstructured":"Stahl SJ, Murray K (1989) Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc Natl Acad Sci 86(16):6283\u20136287","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"3211_CR120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","volume":"6","author":"R Strasser","year":"2008","unstructured":"Strasser R, Stadlmann J, Sch\u00e4hs M et al (2008) Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 6(4):392\u2013402","journal-title":"Plant Biotechnol J"},{"issue":"31","key":"3211_CR121","doi-asserted-by":"crossref","first-page":"20479","DOI":"10.1074\/jbc.M109.014126","volume":"284","author":"R Strasser","year":"2009","unstructured":"Strasser R, Castilho A, Stadlmann J et al (2009) Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous \u03b21, 4-galactosylated N-glycan profile. J Biol Chem 284(31):20479\u201320485","journal-title":"J Biol Chem"},{"issue":"8","key":"3211_CR122","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1073\/pnas.92.8.3358","volume":"92","author":"Y Thanavala","year":"1995","unstructured":"Thanavala Y, Yang Y, Lyons P et al (1995) Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci 92(8):3358\u20133361","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"3211_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-017-0289-y","volume":"15","author":"A Th\u00e9rien","year":"2017","unstructured":"Th\u00e9rien A, B\u00e9dard M, Carignan D et al (2017) A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. J Nanobiotechnol 15(1):1\u201313","journal-title":"J Nanobiotechnol"},{"issue":"31","key":"3211_CR124","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.2174\/1381612811319310011","volume":"19","author":"CE Thuenemann","year":"2013","unstructured":"Thuenemann CE, Lenzi P, Love JA et al (2013) The use of transient expression systems for the rapid production of virus-like particles in plants. Curr Pharm Des 19(31):5564\u20135573","journal-title":"Curr Pharm Des"},{"key":"3211_CR125","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-anchem-071015-041706","author":"M Tschofen","year":"2016","unstructured":"Tschofen M, Knopp D, Hood E, St\u00f6ger E (2016) Plant molecular farming: much more than medicines. Annu Rev Anal Chem. https:\/\/doi.org\/10.1146\/annurev-anchem-071015-041706","journal-title":"Annu Rev Anal Chem"},{"issue":"12","key":"3211_CR126","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2003.10.002","volume":"21","author":"RM Twyman","year":"2003","unstructured":"Twyman RM, Stoger E, Schillberg S et al (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21(12):570\u2013578","journal-title":"Trends Biotechnol"},{"issue":"1\u20134","key":"3211_CR127","first-page":"321","volume":"126","author":"R Ulrich","year":"1992","unstructured":"Ulrich R, Borisova G, Gren E et al (1992) Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Adv Virol 126(1\u20134):321\u2013328","journal-title":"Adv Virol"},{"issue":"15","key":"3211_CR128","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1128\/JVI.77.15.8386-8393.2003","volume":"77","author":"A Varsani","year":"2003","unstructured":"Varsani A, Williamson AL, De Villiers D et al (2003) Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. J Virol 77(15):8386\u20138393","journal-title":"J Virol"},{"issue":"7","key":"3211_CR129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/vaccines9070761","volume":"9","author":"S Venkataraman","year":"2021","unstructured":"Venkataraman S, Hefferon K, Makhzoum A, Abouhaidar M (2021) Combating human viral diseases: will plant-based vaccines be the answer? Vaccines 9(7):761","journal-title":"Vaccines"},{"issue":"3","key":"3211_CR130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4161\/hv.18568","volume":"8","author":"MT Waheed","year":"2012","unstructured":"Waheed MT, Gottschamel J, Hassan SW, L\u00f6ssl AG (2012) Plant-derived vaccines: an approach for affordable vaccines against cervical cancer. Hum Vaccin Immunother 8(3):403\u2013406","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"3211_CR131","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3201\/eid1212.060401","volume":"12","author":"LF Wang","year":"2006","unstructured":"Wang LF, Shi Z, Zhang S et al (2006) Review of bats and SARS. Emerg Infect Dis 12(12):1834","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3211_CR132","first-page":"763","volume":"152","author":"Y Wang","year":"2007","unstructured":"Wang Y, L\u00fc L, Weng S et al (2007) Molecular epidemiology and phylogenetic analysis of a marine fish infectious spleen and kidney necrosis virus-like (ISKNV-like) virus. Adv Virol 152(4):763\u2013773","journal-title":"Adv Virol"},{"issue":"46","key":"3211_CR133","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1016\/j.vaccine.2014.08.079","volume":"32","author":"BJ Ward","year":"2014","unstructured":"Ward BJ, Landry N, Tr\u00e9panier S et al (2014) Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine 32(46):6098\u20136106","journal-title":"Vaccine"},{"issue":"10261","key":"3211_CR134","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","volume":"396","author":"BJ Ward","year":"2020","unstructured":"Ward BJ, Makarkov A, S\u00e9guin A et al (2020) Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u2265 65 years): two multicentre, randomised phase 3 trials. The Lancet 396(10261):1491\u20131503","journal-title":"The Lancet"},{"issue":"6","key":"3211_CR135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41591-021-01370-1","volume":"27","author":"BJ Ward","year":"2021","unstructured":"Ward BJ, Gobeil P, S\u00e9guin A et al (2021) Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med 27(6):1071\u20131078","journal-title":"Nat Med"},{"issue":"47","key":"3211_CR136","doi-asserted-by":"crossref","first-page":"17678","DOI":"10.1073\/pnas.0608869103","volume":"103","author":"S Werner","year":"2006","unstructured":"Werner S, Marillonnet S, Hause G et al (2006) Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. Proc Natl Acad Sci 103(47):17678\u201317683","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3211_CR137","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrmicro1087","volume":"3","author":"S Wildt","year":"2005","unstructured":"Wildt S, Gerngross TU (2005) The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 3(2):119\u2013128","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"3211_CR138","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-2600(21)00075-8","volume":"9","author":"TC Williams","year":"2021","unstructured":"Williams TC, Burgers WA (2021) SARS-CoV-2 evolution and vaccines: cause for concern? Lancet Respir Med 9(4):333\u2013335","journal-title":"Lancet Respir Med"},{"issue":"8","key":"3211_CR139","doi-asserted-by":"crossref","first-page":"e2989","DOI":"10.1371\/journal.pone.0002989","volume":"3","author":"TM Work","year":"2008","unstructured":"Work TM, Aeby GS, Maragos JE (2008) Phase shift from a coral to a corallimorph-dominated reef associated with a shipwreck on Palmyra Atoll. PLoS ONE 3(8):e2989","journal-title":"PLoS ONE"},{"issue":"4","key":"3211_CR140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3748\/wjg.v11.i4.492","volume":"11","author":"HJ Yang","year":"2005","unstructured":"Yang HJ, Chen M, Cheng T et al (2005) Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus. World J Gastroenterol 11(4):492","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3211_CR141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang M, Lai H, Sun H, Chen Q (2017) Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci Rep 7(1):1\u201312","journal-title":"Sci Rep"},{"issue":"12","key":"3211_CR142","doi-asserted-by":"crossref","first-page":"28549","DOI":"10.3390\/ijms161226122","volume":"16","author":"J Yao","year":"2015","unstructured":"Yao J, Weng Y, Dickey A, Wang KY (2015) Plants as factories for human pharmaceuticals: applications and challenges. Int J Mol Sci 16(12):28549\u201328565","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3211_CR143","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/life11010064","volume":"11","author":"G Zahmanova","year":"2021","unstructured":"Zahmanova G, Mazalovska M, Takova K et al (2021) Efficient production of chimeric hepatitis B virus-like particles bearing an epitope of hepatitis E virus capsid by transient expression in Nicotiana benthamiana. Life 11(1):64","journal-title":"Life"},{"issue":"4","key":"3211_CR144","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-3083.2007.01900.x","volume":"65","author":"YL Zhang","year":"2007","unstructured":"Zhang YL, Guo YJ, Wang KY et al (2007) Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Scand J Immunol 65(4):320\u2013328","journal-title":"Scand J Immunol"},{"issue":"51","key":"3211_CR145","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2016.11.026","volume":"34","author":"D Zheng","year":"2016","unstructured":"Zheng D, Chen S, Qu D et al (2016) Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. Vaccine 34(51):6464\u20136471","journal-title":"Vaccine"},{"issue":"5","key":"3211_CR146","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","volume":"15","author":"A Zumla","year":"2016","unstructured":"Zumla A, Chan JF, Azhar EI et al (2016) Coronaviruses\u2014drug discovery and therapeutic options. Nat Rev Drug Discov 15(5):327\u2013347","journal-title":"Nat Rev Drug Discov"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-021-03211-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-021-03211-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-021-03211-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T10:32:04Z","timestamp":1645093924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-021-03211-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3211"],"URL":"https:\/\/doi.org\/10.1007\/s10529-021-03211-0","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}